4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.
Location: United States, California, Emeryville
Employees: 51-200
Total raised: $165M
Founded date: 2013
Investors 7
Date | Name | Website |
- | Octagon Ca... | octagoninv... |
- | Amzak Heal... | amzakhealt... |
- | MBC BioLab... | mbcbiolabs... |
- | Perceptive... | perceptive... |
- | Berkeley C... | berkeleyca... |
- | Chiesi Ven... | chiesivent... |
- | Longevity ... | lvf.vc |
Funding Rounds 2
Date | Series | Amount | Investors |
16.06.2020 | Series C | $75M | - |
06.09.2018 | Series B | $90M | - |
Mentions in press and media 10
Date | Title | Description | Source |
09.02.2022 | 4D Molecular Therapeutics Announces Updated Interim Results ... | Following discontinuation of ERT, AGA activity was stable at 14-fold mean normal level through week ... | marketscre... |
06.10.2021 | Aetion to collaborate with UK's NICE on RWE; 4D's cysti... | New York-based real world evidence, or RWE, firm Aetion is teaming up with the National Inst... | endpts.com... |
18.11.2020 | 4DMT shoots for a $75M IPO, its second attempt to go publ... | Just a few months after withdrawing its IPO filing, 4D Molecular Therapeutics is seeking... | endpts.com... |
16.06.2020 | 4D Molecular Therapeutics Raises $75 Million in Series C Fin... | EMERYVILLE, Calif.--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a clinical-stage leader in th... | citybizlis... |
07.09.2018 | Term Sheet — Friday, September 7 | THREE THINGS Good morning, Term Sheet readers. Paid Content How can you protect what you can't see... | fortune.co... |
06.09.2018 | 4D Molecular Therapeutics Raises $90M in Series B Financing | 4D Molecular Therapeutics, an Emeryville, Calif.-based gene therapy company, closed a $90m Series B ... | finsmes.co... |
06.09.2018 | 4D Molecular Therapeutics Lands $90M | EMERYVILLE, CA, 4D Molecular Therapeutics announced the closing of its $90 million Series B Financ... | vcnewsdail... |
05.09.2018 | 4D raises $90M to move gene therapies into clinical testing ... | Gene therapy company 4D Molecular Therapeutics has raised $90 million in venture capital funds, with... | fiercebiot... |
05.09.2018 | 4D raises $90M to move gene therapies into clinical testing ... | Gene therapy company 4D Molecular Therapeutics has raised $90 million in venture capital funds, with... | fiercebiot... |
27.07.2015 | Horizon to invest up to £10m leveraged funding in molecular ... | Horizon to invest up to £10m leveraged funding in molecular cancer therapeutics 27-07-2015 Horizon... | cambridgen... |